z-logo
open-access-imgOpen Access
Comparative Antipneumococcal Activities of Sulopenem and Other Drugs
Author(s) -
Klaudia Kosowska-Shick,
Lois M. Ednie,
Pamela McGhee,
Peter C. Appelbaum
Publication year - 2009
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01531-08
Subject(s) - streptococcus pneumoniae , medicine , pharmacology , intensive care medicine , microbiology and biotechnology , antibiotics , biology
For 297 penicillin-susceptible, -intermediate, and -resistant pneumococcal strains, the sulopenem MIC50 s were 0.008, 0.06, and 0.25, respectively, and the sulopenem MIC90 s were 0.016, 0.25, and 0.5 μg/ml, respectively. The MIC50 s of amoxicillin for the corresponding strains were 0.03, 0.25, and 2.0 μg/ml, respectively, and the MIC90 s were 0.03, 1.0, and 8.0 μg/ml, respectively. The combination of amoxicillin and clavulanate gave MICs similar to those obtained with amoxicillin alone. The sulopenem MICs were similar to those of imipenem and meropenem. The MICs of ß-lactams increased with those of penicillin G, and among the quinolones tested, moxifloxacin had the lowest MICs. Additionally, 45 strains of drug-resistant type 19A pneumococci were tested by agar dilution and gave sulopenem MIC50 s and MIC90 s of 1.0 and 2.0 μg/ml, respectively. Both sulopenem and amoxicillin (with and without clavulanate) were bactericidal against all 12 strains tested at 2× MIC after 24 h. Thirty-one strains from 10 countries with various penicillin, amoxicillin, and carbapenems MICs, including those with the highest sulopenem MICs, were selected for sequencing analysis of thepbp1a ,pbp2x , andpbp2b regions encoding the transpeptidase active site and MurM. We did not find any correlations between specific penicillin-binding protein-MurM patterns and changes in the MICs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here